237 related articles for article (PubMed ID: 36657812)
1. Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
Shi L; Lu J; Zhong D; Song M; Liu J; You W; Li WH; Lin L; Shi D; Chen Y
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657812
[TBL] [Abstract][Full Text] [Related]
2. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
[TBL] [Abstract][Full Text] [Related]
3. MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD-associated NSCLC.
Yin Y; Zeng A; Abuduwayiti A; Xu Z; Chen K; Wang C; Fang X; Wang J; Jiang G; Dai J
Cancer Med; 2024 Mar; 13(6):e7112. PubMed ID: 38509769
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.
Sundström P; Dutta N; Rodin W; Hallqvist A; Raghavan S; Quiding Järbrink M
Oncoimmunology; 2024; 13(1):2312631. PubMed ID: 38343750
[TBL] [Abstract][Full Text] [Related]
5. Mucosal-associated invariant T cells reduce and display tissue-resident phenotype with elevated IL-17 producing capacity in non-small cell lung cancer.
Ouyang L; Wu M; Zhao J; Jiang L; Shen Z; Cheng X; Wang W; Wu X; Cao X; Weng X
Int Immunopharmacol; 2022 Dec; 113(Pt B):109461. PubMed ID: 36435063
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
8. Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies.
Yao T; Shooshtari P; Haeryfar SMM
Front Immunol; 2020; 11():1691. PubMed ID: 32849590
[TBL] [Abstract][Full Text] [Related]
9. High HPK1
Zhang J; Ren Z; Hu Y; Shang S; Wang R; Ma J; Zhang Z; Wu M; Wang F; Yu J; Chen D
Int Immunopharmacol; 2024 Jan; 127():111363. PubMed ID: 38101218
[TBL] [Abstract][Full Text] [Related]
10. Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy.
Jarvis EM; Collings S; Authier-Hall A; Dasyam N; Luey B; Nacey J; Painter GF; Delahunt B; Hermans IF; Weinkove R
Front Immunol; 2021; 12():748741. PubMed ID: 34737749
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
12. Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
Rodin W; Sundström P; Ahlmanner F; Szeponik L; Zajt KK; Wettergren Y; Bexe Lindskog E; Quiding Järbrink M
Cancer Immunol Immunother; 2021 Dec; 70(12):3461-3475. PubMed ID: 33885944
[TBL] [Abstract][Full Text] [Related]
13. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
Melo AM; O'Brien AM; Phelan JJ; Kennedy SA; Wood NAW; Veerapen N; Besra GS; Clarke NE; Foley EK; Ravi A; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; Conroy MJ; Hogan AE; O'Sullivan J; Dunne MR
Front Immunol; 2019; 10():1580. PubMed ID: 31354725
[TBL] [Abstract][Full Text] [Related]
14. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
Liu C; Zheng S; Wang Z; Wang S; Wang X; Yang L; Xu H; Cao Z; Feng X; Xue Q; Wang Y; Sun N; He J
Cancer Commun (Lond); 2022 Sep; 42(9):828-847. PubMed ID: 35811500
[TBL] [Abstract][Full Text] [Related]
15. Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma.
Duan M; Goswami S; Shi JY; Wu LJ; Wang XY; Ma JQ; Zhang Z; Shi Y; Ma LJ; Zhang S; Xi RB; Cao Y; Zhou J; Fan J; Zhang XM; Gao Q
Clin Cancer Res; 2019 Jun; 25(11):3304-3316. PubMed ID: 30723143
[TBL] [Abstract][Full Text] [Related]
16. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer.
Liu C; Yang L; Xu H; Zheng S; Wang Z; Wang S; Yang Y; Zhang S; Feng X; Sun N; Wang Y; He J
BMC Med; 2022 May; 20(1):187. PubMed ID: 35550592
[TBL] [Abstract][Full Text] [Related]
18. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
19. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
20. Characterization and function of circulating mucosal-associated invariant T cells and γδT cells in oral lichen planus.
Yang JY; Wang F; Zhou G
J Oral Pathol Med; 2022 Jan; 51(1):74-85. PubMed ID: 34637577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
